Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05490550 · ClinicalTrials.gov registry record · NA
Comparing Insomnia Care As Usual to Digital Augmentation (CICADA)
A NA study of Chronic Insomnia, sponsored by Noctem.
- Recruiting
- Registry status
- NA
- Development phase
- 188
- Enrollment target
- 1
- Study location
NCT05490550: Recruiting NA study of Chronic Insomnia, sponsored by Noctem.
NCT05490550 is a NA study of Chronic Insomnia that is actively recruiting participants, run by Noctem. The registered enrollment target is 188 participants, below the 25,382-participant average among 11 other Chronic Insomnia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05490550, a NA study of Chronic Insomnia, is actively recruiting participants, sponsored by Noctem.
- RECRUITING
- Registry status
- NA
- Development phase
- 188 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this pragmatic non-inferiority randomized clinical trial is to evaluate whether Cognitive Behavioral Treatment of Insomnia (CBTI) delivered through a clinical decision support digital platform is non-inferior to insomnia care delivered as usual at three military treatment facilities for treatment of insomnia, symptoms of depression and anxiety, and treatment satisfaction.
Conditions Studied
Interventions
- BEHAVIORAL COAST-enhanced CBTI
- BEHAVIORAL Military Treatment Facility Insomnia Care As Usual
Study Locations (1)
Washington
- Madigan Army Medical Center - Lakewood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2023-08-16 |
| Est. Completion | 2025-03 |
| Phase | NA |
What NCT05490550 shows while recruiting
NCT05490550 is an interventional study that assigns participants to a tested intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 25,382-participant average among 11 other Chronic Insomnia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Chronic Insomnia appearing as the primary indexed condition, and to 2 interventions - of which COAST-enhanced CBTI is the first listed.
NCT05490550 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT05490550 about?
NCT05490550 is a clinical study titled "Comparing Insomnia Care As Usual to Digital Augmentation (CICADA)". The purpose of this pragmatic non-inferiority randomized clinical trial is to evaluate whether Cognitive Behavioral Treatment of Insomnia (CBTI) delivered through a clinical decision support digital platform is non-inferior to insomnia care delivered as usual at three military treatment facilities f...
What is the current status of trial NCT05490550?
This trial is currently recruiting. It is a NA study. The enrollment target is 188 participants. The study started on 2023-08-16. Estimated completion is 2025-03.
What conditions does trial NCT05490550 study?
This clinical trial studies the following conditions: Chronic Insomnia.
What interventions are being tested in trial NCT05490550?
The interventions under investigation include: COAST-enhanced CBTI (BEHAVIORAL), Military Treatment Facility Insomnia Care As Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT05490550?
This trial is sponsored by Noctem, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05490550 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Insomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05490550's enrollment target sits among peer trials
188 4th of 11 higher than 8 of 11 other Chronic Insomnia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Insomnia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Sleep and Reducing Opioid Use in Individuals With Chronic Pain
RECRUITING · NA
-
Insomnia Behavioral Intervention Study
RECRUITING · NA
-
The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients
ACTIVE NOT RECRUITING · NA
-
Sleep and Pain Intervention for Chronic Widespread Pain Pilot Study
COMPLETED · NA
-
Naturalistic Monitoring and Treatment of Chronic Insomnia
COMPLETED · NA
-
Brief Behavioral Treatment for Insomnia in Cancer Survivors
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI